Actively Recruiting
A Randomized Clinical Trial of a Novel Drug Education and Diversion Program (iDECIDE) for Middle and High School Students
Led by Massachusetts General Hospital · Updated on 2025-10-30
300
Participants Needed
1
Research Sites
245 weeks
Total Duration
On this page
Sponsors
M
Massachusetts General Hospital
Lead Sponsor
M
Massachusetts Department of Health
Collaborating Sponsor
AI-Summary
What this Trial Is About
The primary goal of this study is to test the effectiveness of the iDECIDE (Drug Education Curriculum: Intervention, Diversion, and Empowerment) curriculum, a novel drug education and diversion program, in approximately 300 middle and high school students, who have violated their school substance use policies in the past month, as an alternative to punitive school responses for school-based substance use infractions. This randomized controlled trial will test the hypothesis that adolescents randomized to the iDECIDE curriculum will have improved substance use outcomes (i.e., knowledge, attitudes, and behavior) compared to adolescents in a waitlist control group. The outcomes of this study will measure knowledge of drug effects and brain development, perceptions of harm from substance use, willingness to quit or reduce use, and substance use behavior.
CONDITIONS
Official Title
A Randomized Clinical Trial of a Novel Drug Education and Diversion Program (iDECIDE) for Middle and High School Students
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Currently enrolled in middle or high school
- Violated school substance use policy within approximately the past month at the time of screening
- Has a parent or legal guardian able and willing to provide written informed consent if under 18
- Competent and willing to provide written informed assent if under 18, or written informed consent if 18 or older
- Able to commit to 9 study visits over approximately one year
- Able to safely participate in the protocol and appropriate for outpatient care, per investigator
- Has access to a reliable internet connection and a device that can run Zoom
- Able to read and write comfortably in a language spoken by study staff
You will not qualify if you...
- Ever received substance use treatment in an inpatient or specialty care setting
- Ever engaged in intravenous (IV) drug use
- Current daily use of alcohol, non-medical benzodiazepines, and/or opioid use
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Actively Recruiting
Research Team
R
Randi M Schuster, PhD
CONTACT
K
Kendall Roberts
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here